Core Viewpoint - The SLM Corporation, also known as Sallie Mae, is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding the company's loan delinquency rates and loss mitigation programs during a specified class period [1][3]. Group 1: Class Action Details - Investors in SLM securities from July 25, 2025, to August 14, 2025, can seek appointment as lead plaintiff in the class action lawsuit by February 17, 2026 [1]. - The lawsuit, titled Zappia v. SLM Corporation, accuses SLM and its executives of making false statements and failing to disclose significant increases in early-stage delinquencies [3][4]. Group 2: Allegations and Impact - The lawsuit alleges that SLM overstated the effectiveness of its loss mitigation and loan modification programs, as well as the overall stability of its private education loan delinquency rates [3]. - A report from investment bank TD Cowen indicated that July 2025 delinquencies increased by 49 basis points month-over-month, contradicting SLM's CFO's claims of normal seasonal trends, leading to an approximate 8% drop in SLM's stock price following the report [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who suffered losses during the class period to seek the role of lead plaintiff, representing the interests of all class members [5]. - The lead plaintiff has the authority to select a law firm for the lawsuit and does not need to be the lead plaintiff to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [6].

Core Viewpoint - Investors with significant losses in Ramaco Resources, Inc. have until March 31, 2026, to file lead plaintiff applications in a securities class action lawsuit [1] Group 1 - The lawsuit pertains to investors who purchased or acquired Ramaco's securities between July 31, 2025, and October 23, 2025, inclusive [1]

Core Viewpoint - Halper Sadeh LLC is investigating several companies for potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to their sales transactions [1][2]. Group 1: Company Investigations - Stellar Bancorp, Inc. is being investigated regarding its sale to Prosperity Bancshares, Inc. for 0.3803 shares of Prosperity common stock and $11.36 in cash for each share of Stellar common stock [1]. - Gold Resource Corporation's sale to Goldgroup Mining Inc. involves an exchange of 1.4476 common shares of Goldgroup for each share of Gold Resource common stock [2]. - SkyWater Technology, Inc. is under scrutiny for its sale to IonQ, which includes $15.00 in cash and $20.00 in shares of IonQ common stock for each share of SkyWater [2]. Group 2: Legal Rights and Options - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3]. - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4].

Core Viewpoint - A class action lawsuit has been filed against Bath & Body Works, Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Southern District of Ohio, captioned Lingam v. Bath & Body Works, Inc., et al., No. 2:26-cv-00039 [3]. - Investors have until March 16, 2026, to request to be appointed to lead the case [3]. Group 2: Company Performance and Strategy - Bath & Body Works is a specialty retailer focusing on home fragrance and body care products, exploring product categories beyond its core business, including men's products, lip care, hair care, and laundry [4]. - The company claimed that customers were responding favorably to its innovations and that its strategy was effective in driving topline growth through category adjacencies [5]. Group 3: Stock Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 financial results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53, leading to a stock price drop of $2.18 per share, or 6.9% [6]. - Following the Q3 2025 financial results on November 20, 2025, which revealed that the strategy of pursuing adjacencies had not grown the customer base, the stock price fell by $5.22 per share, or 24.8% [7].

New York, New York--(Newsfile Corp. - January 31, 2026) - Leading international securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfala ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health is accused of misrepresenting its process for determining the collectability of accounts receivable, claiming to rely on "detailed reviews of historical collections" while actually using a "180-day cliff" method [4]. - This misrepresentation allegedly allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million decrease in revenue for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5].

Core Viewpoint - Carvana Co. is under investigation for potential violations of federal securities laws due to significant stock price drops linked to claims of accounting improprieties [2][3]. Company Overview - Carvana is an online e-commerce platform and used-car retailer that enables customers to buy, sell, or finance vehicles entirely online. A substantial portion of its revenue is derived from online vehicle sales and auto loans, which are often securitized or sold to external parties [3]. Investigation Details - The investigation by Bleichmar Fonti & Auld LLP focuses on whether Carvana overstated its earnings and improperly accounted for related party transactions [3]. - Gotham City Research LLC issued a report alleging that Carvana's financial results are closely tied to a network of related party entities controlled by Ernest Garcia II, which includes DriveTime, Bridgecrest, and GoFi. The report claims that these relationships led to an overstatement of Carvana's earnings by over $1 billion [4]. Stock Performance - Following the release of the Gotham City report on January 28, 2026, Carvana's stock price fell over 20%, dropping from $474.06 per share at market open to a low of $374.55 per share [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Smart Digital Group Limited due to allegations of securities law violations, urging affected investors to contact them for legal options [2][5]. Group 1: Allegations Against Smart Digital - The complaint alleges that Smart Digital and its executives made false or misleading statements and failed to disclose significant risks related to market manipulation and fraudulent promotion schemes [5]. - Specific allegations include the use of social media misinformation and impersonation by individuals posing as financial professionals to manipulate the stock price [5]. - It is claimed that insiders used offshore accounts to facilitate the dumping of shares during a price inflation campaign, which was not disclosed in the company's public statements [5]. Group 2: Stock Price Collapse and SEC Actions - On September 26, 2025, Smart Digital's stock price fell by 86.4%, closing at $1.85 per share, following a trading halt by NASDAQ due to volatility [6]. - The SEC suspended trading of Smart Digital securities from September 29, 2025, to October 10, 2025, citing potential manipulation through social media recommendations designed to inflate stock prices [6]. - Following the SEC's suspension, NASDAQ also suspended trading in Smart Digital securities pending further information, with no clear timeline for resumption [6]. Group 3: Legal Proceedings and Class Action - Investors who suffered losses are encouraged to seek the role of lead plaintiff in a federal securities class action against Smart Digital, with a deadline set for March 16, 2026 [2][7]. - The lead plaintiff is defined as the investor with the largest financial interest in the case, who will oversee the litigation on behalf of the class [7]. - Faruqi & Faruqi, LLP is also seeking information from whistleblowers, former employees, and shareholders regarding Smart Digital's conduct [8].

Core Viewpoint - Kahn Swick & Foti, LLC has initiated class action securities lawsuits against Coupang, Inc. for alleged securities fraud affecting investors during the specified period [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged securities fraud between May 7, 2025, and December 16, 2025 [2]. - Coupang and certain executives are accused of failing to disclose material information, violating federal securities laws [3]. - Allegations include inadequate cybersecurity protocols that allowed unauthorized access to sensitive customer information for nearly six months, leading to heightened regulatory and legal scrutiny [3]. - The defendants allegedly failed to report the data breach in compliance with Securities and Exchange Commission reporting rules, rendering their public statements materially false and misleading [3]. Group 2: Legal Proceedings - The first-filed case is Barry v. Coupang, Inc., et al., No. 25-cv-10795, with a subsequent case, Lee v. Coupang, Inc., et al., No. 26-cv-00047, expanding the class period [4]. - Investors have until February 17, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this role [4]. Group 3: About Kahn Swick & Foti, LLC - Kahn Swick & Foti, LLC is recognized as one of the premier boutique securities litigation law firms in the U.S., with a ranking among the top 10 firms nationally based on total settlement value [4]. - The firm serves a diverse clientele, including public and private institutional investors, as well as retail investors, seeking recoveries for investment losses due to corporate fraud or malfeasance [4].

Company Overview - Travere Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for individuals with rare kidney and metabolic diseases in the United States [2]. Investigation Details - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Travere, specifically whether the company and certain executives made materially false and/or misleading statements or omitted material information regarding Travere's business and operations [1][2]. Law Firm Background - Robbins Geller is recognized as one of the leading law firms in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in securities-related class action cases in 2024, which is more than the next five law firms combined [3].